Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Wei
Timothy D Henry

Showing results (331-340 of 754) with videos related to

Pageof 76
Sort By:
The American Journal of Cardiology|April 26, 2006
Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarctionMarc C Newell, Christopher R Henry, Christopher J G Sigakis, et al.
American Heart Journal|February 16, 2023
Microvascular obstruction identifies a subgroup of patients who benefit from stem cell therapy following ST-elevation myocardial infarctionSarah J Davidson, Jerome Roncalli, Daniel Surder, et al.
Heliyon|July 24, 2023
Association of triglyceride levels with adverse cardiovascular events in patients with ST-segment elevation myocardial infarctionMehmet Yildiz, Michael D Miedema, Avinash Murthy, et al.
American Heart Journal|September 29, 2014
The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: the FRIENDS registrySue Duval, Hong H Keo, Niki C Oldenburg, et al.
Critical Pathways in Cardiology|July 26, 2014
Ranolazine refractory angina registry: 1-year resultsNoel M Bennett, Vijay Iyer, Theresa L Arndt, et al.
Circulation|September 21, 2011
Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarctionMichael D Miedema, Marc C Newell, Sue Duval, et al.
American Heart Journal|September 10, 2010
Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarctionJay H Traverse, David H McKenna, Karen Harvey, et al.
Circulation. Cardiovascular Quality and Outcomes|December 7, 2020
Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care PatientsJacob C Jentzer, Patrick R Lawler, Sean van Diepen, et al.
Clinical & Translational Immunology|April 22, 2026
Adaptive immune response to the autoantigen LL-37 differentiates atherosclerotic cardiovascular disease phenotypesPaul C Dimayuga, Kuang-Yuh Chyu, Jianchang Zhou, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Latest from the WISE: Contributions to the Understanding of Ischemia and Heart Failure among Women with No Obstructive Coronary ArteriesBreanna Hansen, Michael D Nelson, Eileen M Handberg, et al.
Pageof 76

Showing results (331-340 of 754) with videos related to

Sort By:
Pageof 76
The American Journal of Cardiology|April 26, 2006
Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarctionMarc C Newell, Christopher R Henry, Christopher J G Sigakis, et al.
American Heart Journal|February 16, 2023
Microvascular obstruction identifies a subgroup of patients who benefit from stem cell therapy following ST-elevation myocardial infarctionSarah J Davidson, Jerome Roncalli, Daniel Surder, et al.
Heliyon|July 24, 2023
Association of triglyceride levels with adverse cardiovascular events in patients with ST-segment elevation myocardial infarctionMehmet Yildiz, Michael D Miedema, Avinash Murthy, et al.
American Heart Journal|September 29, 2014
The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: the FRIENDS registrySue Duval, Hong H Keo, Niki C Oldenburg, et al.
Critical Pathways in Cardiology|July 26, 2014
Ranolazine refractory angina registry: 1-year resultsNoel M Bennett, Vijay Iyer, Theresa L Arndt, et al.
Circulation|September 21, 2011
Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarctionMichael D Miedema, Marc C Newell, Sue Duval, et al.
American Heart Journal|September 10, 2010
Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarctionJay H Traverse, David H McKenna, Karen Harvey, et al.
Circulation. Cardiovascular Quality and Outcomes|December 7, 2020
Systemic Inflammatory Response Syndrome Is Associated With Increased Mortality Across the Spectrum of Shock Severity in Cardiac Intensive Care PatientsJacob C Jentzer, Patrick R Lawler, Sean van Diepen, et al.
Clinical & Translational Immunology|April 22, 2026
Adaptive immune response to the autoantigen LL-37 differentiates atherosclerotic cardiovascular disease phenotypesPaul C Dimayuga, Kuang-Yuh Chyu, Jianchang Zhou, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Latest from the WISE: Contributions to the Understanding of Ischemia and Heart Failure among Women with No Obstructive Coronary ArteriesBreanna Hansen, Michael D Nelson, Eileen M Handberg, et al.
Pageof 76